Skip To Main Content
Barry J. Make on Muck Rack

Barry J. Make

As seen in: Nature, JAMA (The Journal of the American Medical Association), Chest, Texas Medical Center, Annals of Family Medicine, Mayo Clinic Proceedings, Respiratory Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barry J.

Contact Barry J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recommendations for return of secondary genomic findings in observational cohort studies

|
By Iftikhar J. Kullo, Carol Horowitz, Lisa Bastarache, Benjamin E. Berkman, Leslie G. Biesecker, Kyle B Brothers, April P. Carson, Keith Diaz, Richard Gibbs, Robert Green, Heather Hampel, Candace Henley, Jodell E. Linder, Gail P. Jarvik, Sadiya Khan, Barry J. Make, Samuli Ripatti, Juliann Savatt, Gabriel Q. Shaibi, Stephen Sodeke, Colin Wise, Ronit Yarden, Mimsie Robinson
| Nature Verified
Abstract The return of secondary genomic findings (ROSF) to participants in observational cohort studies has evolved from a topic of debate to an accepted standard. This Perspective synthesizes the proceedings of a 2024 National Heart, Lung and Blood Institute-sponsored workshop and the broader literature to provide updated guidance for ROSF.
Open in Who Shared Issue with article?

"Returning Incidentally Discovered Hepatitis C RNA-Seq Results to COPDG" by Edwin K Silverman, Arthur Y Kim et al.

|
By Edwin K. Silverman, Arthur Kim, Barry J. Make, Elizabeth Regan Verified
| Texas Medical Center
Abstract The consequences of returning infectious pathogen test results identified incidentally in research studies have not been well-studied. Concerns include identification of an important health issue for individuals, accuracy of research test results, public health impact, potential emotional distress for participants, and need for IRB permissions.
Open in Who Shared Issue with article?

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients

|
By Anthony N. Gerber, Barry J. Make, Michael E. Wechsler, R. Lee Reinhardt
| openres.ersjournals.com
Introduction Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targeting the ancestral (Wuhan-Hu-1/2019) viral spike (S) protein has been broadly effective at limiting infection and severe coronavirus disease 2019 (COVID-19) [1–6]. With respect to SARS-CoV-2 infection, both the humoral and cell-mediated arms of the adaptive response are important for achieving optimal control of COVID-19 [7].
Open in Who Shared Issue with article?
See all 7 articles